2022
DOI: 10.4187/respcare.10311
|View full text |Cite
|
Sign up to set email alerts
|

2021 Year in Review: Pediatric Mechanical Ventilation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 69 publications
0
2
0
Order By: Relevance
“…The CSF-TP levels of the 103 children were 0.93 (0.65-1.50) g/L. The interval from onset to lumbar puncture was 11 (7)(8)(9)(10)(11)(12)(13)(14)(15) days. Compared with the nonrespiratory insufficiency group, the respiratory insufficiency group showed a higher HFGS at admission (p < 0.001), more facial and/or bulbar weakness (p ¼ 0.002), and shorter onset to admission interval (p ¼ 0.017) (►Table 1, ►Figs.…”
Section: Resultsmentioning
confidence: 96%
See 1 more Smart Citation
“…The CSF-TP levels of the 103 children were 0.93 (0.65-1.50) g/L. The interval from onset to lumbar puncture was 11 (7)(8)(9)(10)(11)(12)(13)(14)(15) days. Compared with the nonrespiratory insufficiency group, the respiratory insufficiency group showed a higher HFGS at admission (p < 0.001), more facial and/or bulbar weakness (p ¼ 0.002), and shorter onset to admission interval (p ¼ 0.017) (►Table 1, ►Figs.…”
Section: Resultsmentioning
confidence: 96%
“… 1 2 Respiratory insufficiency is a potential life-threatening complication of GBS and it is associated with higher incidence of morbidity. 1 2 7 8 Therefore, predicting respiratory insufficiency is necessary for the proper management of children with GBS. The validated predictors of respiratory insufficiency include serum albumin, forced vital capacity (FVC), negative inspiratory force, and the Erasmus GBS Respiratory Insufficiency Scale (EGRIS), as well as rapid disease progression, inability to cough, stand, or raise the head, bulbar dysfunction, bilateral facial weakness, insufficient foot flexion (at the end of immunotherapy), and dystonia.…”
Section: Introductionmentioning
confidence: 99%